"Le Centre Hospitalier de Flers est constitué de 2 sites sur la commune de Flers. Le Centre Hospitalier J. Monod où se trouve la majorité des services, et le Centre Maubert, qui accueille l'Etablissement d'Hébergement pour Personnes Âgées Dépendantes (EHPAD), l'Institut de Formation en Soins Infirmiers (IFSI) et la maison thérapeutique. Le Centre Hospitalier de Flers est l'hôpital support du Groupement Hospitalier de Territoire "Collines de Normandie". Ce G.H.T. regroupe le CHIC des Andaines (la Ferté-Macé et Domfront), Flers et Vire."

During the past decade, Centre hospitalier de Flers conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre hospitalier de Flers" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored, "Centre Francois Baclesse" with 1 trials sponsored and "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre hospitalier de Flers" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "Institut National de la Santé et de la Recherche Médical (INSERM) 1086 (Pr Guy LAUNOY) Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Centre hospitalier de Flers" are "Colorectal Cancer" (2 trials), "ALK Gene Mutation" (1 trials), "BRAF Gene Mutation" (1 trials), "Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Centre hospitalier de Flers" in a lesser frequency.

Most popular intervention types in "Centre hospitalier de Flers" are "Drug" (3 trials), "Behavioral" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5Fluorouracil bolus" (1 trials), "5Fluorouracil continu" (1 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials) and "FOLFOX + panitumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre hospitalier de Flers" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Centre hospitalier de Flers". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre hospitalier de Flers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre hospitalier de Flers, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".